Avestar Capital’s Repligen RGEN Stock Holding History

Avestar Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,921	Closed	-$774K	–	460
2021 Q4	$774K	Sell	2,921 -1,161	-28%	-$313K	0.09%	195
2021 Q3	$1.18M	Buy	+4,082	New	+$1.05M	0.15%	159
2019 Q3	–	Sell	-160	Closed	-$13K	–	688
2019 Q2	$13K	Hold	160	–	–	0.01%	467
2019 Q1	$9K	Hold	160	–	–	0.01%	493
2018 Q4	$8K	Hold	160	–	–	0.01%	472
2018 Q3	$8K	Hold	160	–	–	﹤0.01%	494
2018 Q2	$7K	Hold	160	–	–	﹤0.01%	518
2018 Q1	$5K	Hold	160	–	–	﹤0.01%	541
2017 Q4	$5K	Buy	+160	New	+$5.79K	﹤0.01%	555

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Avestar Capital's RGEN Position: Q1 2022 in Review

Avestar Capital sold out of Repligen (RGEN) in Q1 2022, closing a stake of 2,921 shares — an estimated $774K sold.

Avestar Capital first reported a position in RGEN in Q4 2017 and held it in 9 quarters. The position peaked at $1.18M in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

Avestar Capital reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
Avestar Capital sold 2,921 Repligen shares in Q1 2022, an estimated $774K.
Avestar Capital first reported a position in Repligen in Q4 2017 and held it in 9 quarters.
Avestar Capital's Repligen position peaked at $1.18M in Q3 2021.
450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Avestar Capital's 13F filing for Q1 2022, filed 26 Apr 2022.